Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Safety and Feasibility of an Integrated Fabric-Type Orthosis for Gait and Balance Improvement in Geriatric Patients

12 de noviembre de 2026 actualizado por: Seoul National University Hospital

Safety and Feasibility of an Integrated Fabric- Type Orthosis With Muscle-Mimicking and Proprioception-Enhancing Functions for Improving Gait and Balance in Geriatric Patients: Pilot Clinical Trial

This pilot clinical trial aims to evaluate the safety and feasibility of an integrated fabric-type orthosis with muscle-mimicking and proprioception-enhancing functions in older adults with geriatric conditions affecting gait and balance. The wearable orthosis provides lower-limb assistance through a fabric-based actuation system and vibrotactile proprioceptive stimulation. Thirty participants aged 65 years or older will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. Outcome measures include gait performance, postural sway, one-leg standing balance, joint position sense, muscle activation, physiological responses, fatigue, and device-related adverse events. The study is designed as an exploratory pilot trial to assess the clinical applicability, usability, and safety of the wearable assistive device in geriatric patients.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Estimado)

30

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: junghyun kim, prof
  • Número de teléfono: 82+1088632341
  • Correo electrónico: kiking0@naver.com

Ubicaciones de estudio

    • Jongno
      • Seoul, Jongno, Corea del Sur, 03080
        • Reclutamiento
        • Seoul National University Hospital
        • Contacto:
          • junghyun kim, prof
          • Número de teléfono: 82+1059657182
          • Correo electrónico: kiking0@naver.com

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

65 años y mayores (Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

Eligibility for participation in the study requires that all the following criteria are met:

  1. Age: Participants must be 65 years of age or older.

  2. Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.

  3. Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:

    • Muscle Strength: Handgrip strength of <28 kg for men and <18 kg for women.
    • Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
    • Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass <7.0 kg/m² for men and <5.7 kg/m² for women. (2)Diabetes:
    • Diagnosed distal symmetric polyneuropathy.
    • Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
    • Kellgren-Lawrence grade ≥2.
    • Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).

Exclusion Criteria:

Individuals meeting any of the following criteria will be excluded from study participation:

  1. Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.

  2. Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.

  3. Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.

  4. Independent Walking Inability: Cannot walk independently without the aid of a walking device.

  5. Other Significant Diseases or Conditions:

    • Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
    • Orthopedic or musculoskeletal conditions severely affecting lower limb function.
    • Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
    • Respiratory diseases requiring regular oxygen therapy.
    • Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
    • Severe psychiatric disorders like schizophrenia or bipolar disorder.
  6. Other Exclusionary Factors:

    • Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
    • Severe back pain or any other condition affecting mobility not already listed.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Otro
  • Asignación: N / A
  • Modelo Intervencionista: Asignación de un solo grupo
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Integrated Fabric-Type Orthosis Evaluation

Participants will undergo gait, balance, proprioception, and electromyography assessments under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on. The wearable fabric-type orthosis provides muscle-mimicking lower-limb assistance and proprioception-enhancing vibrotactile stimulation for gait and balance support in older adults.

A wearable fabric-type lower-limb orthosis integrating muscle-mimicking actuation and proprioception-enhancing vibrotactile stimulation. The device is designed to assist knee and ankle movements during gait and balance activities in older adults with gait and balance impairments. Participants will be evaluated under three conditions: without the orthosis, with the orthosis powered off, and with the orthosis powered on.

Otros nombres:
  • Soft Exosuit

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Change in Blood Pressure From Before to After Functional Assessment
Periodo de tiempo: Immediately before and after the functional assessment at each study visit

Systolic and Diastolic blood pressure will be measured in millimeters of mercury (mmHg) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Heart Rate From Before to After Functional Assessment
Periodo de tiempo: Immediately before and after the functional assessment at each study visit

Heart rate will be measured in beats per minute (bpm) before and after completion of the functional assessment, which includes gait and balance tests performed under the designated orthosis conditions.

Immediately before and after the functional assessment at each study visit
Change in Perceived Exertion From Before to After Functional Assessment
Periodo de tiempo: Immediately before and after the functional assessment at each study visit

Perceived exertion will be assessed using the Borg Scale before and after completion of the functional assessment. Higher scores indicate greater perceived exertion.

Immediately before and after the functional assessment at each study visit
Change in Pain Intensity From Before to After Functional Assessment
Periodo de tiempo: Immediately before and after the functional assessment at each study visit

Pain intensity will be assessed using the Numeric Rating Scale (NRS) before and after completion of the functional assessment. Scores range from 0 to 10, with higher scores indicating greater pain intensity.

Immediately before and after the functional assessment at each study visit

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
6-Minute Walk Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate walking endurance and functional mobility by measuring the maximum walking distance achieved within six minutes.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
10-Meter Walk Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess gait speed and short-distance walking performance under different orthosis conditions.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
20-Meter Walk Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess walking speed and gait performance over a longer walking distance.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Surface Electromyography
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate lower-limb muscle activation patterns during walking using surface electromyography (sEMG).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Static One-Leg Standing Balance Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate static balance ability by measuring the duration participants can maintain single-leg standing.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Postural Sway
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To assess postural stability during quiet standing using center of pressure (COP)-based balance measurements.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Passive Joint Position Reproduction Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring passive knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Active Joint Position Reproduction Test
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

To evaluate proprioceptive accuracy by measuring active knee joint position reproduction error.

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Participant Satisfaction
Periodo de tiempo: Immediately post-brace activation (power on)

To assess participant satisfaction, comfort, perceived usability, and overall acceptance of the wearable orthosis.

Immediately post-brace activation (power on)
Gait Speed
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Gait speed measured using the GAITRite system, reported in meters per second (m/s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Cadence
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Cadence measured using the GAITRite system, reported in steps per minute (steps/min).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Step Length
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Step length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stride Length
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stride length measured using the GAITRite system, reported in centimeters (cm).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Single Support Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Single support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Double Support Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Double support time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Stance Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Stance time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)
Swing Time
Periodo de tiempo: 1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Swing time measured using the GAITRite system, reported in seconds (s).

1.Baseline (before brace application) 2.Immediately post-brace application (power off), 3.Immediately post-brace activation (power on)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Director de estudio: hyungik shin, prof, Seoul National University Hospital

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

17 de junio de 2026

Finalización primaria (Estimado)

31 de diciembre de 2027

Finalización del estudio (Estimado)

31 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

21 de mayo de 2026

Primero enviado que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

12 de noviembre de 2026

Última verificación

1 de mayo de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir